An IOL is the artificial lens placed in a person’s eye to restore vision after a cataract has been removed. While traditional monofocal IOLs are not designed to eliminate the need for glasses, multifocal IOLs provide quality vision at multiple distances and reduce or eliminate the need for glasses.  The new lenses approved by the U.S. Food and Drug Administration were developed by Abbott Medical Optics and are known as TECNIS Multifocal +2.75D and +3.25D IOLs. These Multifocal IOLs provide excellent vision at near, intermediate and far distance.

The previously available TECNIS Multifocal +4.0D is suited for people favoring near vision-related activities, such as reading a book. The TECNIS Multifocal +3.25D IOL is suited for people who favor activities at longer reading distances, such as reading a hand-held device like a tablet. The TECNIS Multifocal +2.75D IOL is suited for people who favor activities done with intermediate vision, such as table top computers and reading labels while grocery shopping.

“My patients are extremely satisfied with the new TECNIS Multifocal lenses,” said Dr. Kerry Assil. “Many of them are able to read easily, not only up close, but at intermediate distance as well, and in all lighting conditions. This improved vision following cataract surgery helps people live the active lives they desire.”  If you or a loved one are experiencing cloudy vision possibly caused by a cataract, know that you have growing options with cataract surgery. We encourage you to call Assil Eye Institute at (310) 651-2300 schedule an appointment with Dr. Assil.

Dr. Assil and the new TECNIS Multifocal lens from Abbott Medical can also be seen at: CNNMoneyEuropean Pharmaceutical Review, and Pharmacy Times.